Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
2.350
-0.010 (-0.42%)
Nov 4, 2024, 4:00 PM EST - Market closed
Armata Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Net Income | -67.04 | -69.05 | -36.92 | -23.16 | -22.18 | -19.48 | |
Depreciation & Amortization | 1.15 | 0.97 | 0.89 | 1.17 | 1.11 | 1.35 | |
Loss (Gain) From Sale of Assets | 0.08 | 0.08 | - | - | - | 0.66 | |
Stock-Based Compensation | 1.69 | 0.94 | 3.11 | 2.88 | 3.48 | 4.27 | |
Other Operating Activities | 27.28 | 29.28 | - | -1.25 | 0.2 | -0.2 | |
Change in Accounts Payable | -2.22 | 0.04 | 3.67 | 0.18 | 0.54 | -1.37 | |
Change in Other Net Operating Assets | 0.52 | -9.69 | -3.23 | -3.41 | -1.42 | -0.82 | |
Operating Cash Flow | -38.55 | -47.42 | -32.48 | -23.58 | -18.27 | -15.58 | |
Capital Expenditures | -7.53 | -8.14 | -2.21 | -1.3 | -0.82 | -0.22 | |
Sale of Property, Plant & Equipment | 0.01 | 0.01 | - | - | - | 0.09 | |
Cash Acquisitions | - | - | - | - | - | 3.01 | |
Investing Cash Flow | -7.52 | -8.13 | -2.21 | -1.3 | -0.82 | 2.88 | |
Short-Term Debt Issued | - | - | - | - | 0.72 | - | |
Long-Term Debt Issued | - | 54.03 | - | - | - | - | |
Total Debt Issued | 59.69 | 54.03 | - | - | 0.72 | - | |
Net Debt Issued (Repaid) | 59.69 | 54.03 | - | - | 0.72 | - | |
Issuance of Common Stock | 0.14 | 0.01 | 44.52 | 26.93 | 23.06 | 9.98 | |
Repurchase of Common Stock | -0.04 | -0.04 | - | - | - | - | |
Other Financing Activities | - | - | -0.5 | -1.41 | -0.57 | -1 | |
Financing Cash Flow | 59.78 | 53.99 | 44.02 | 25.52 | 23.21 | 8.98 | |
Net Cash Flow | 13.71 | -1.57 | 9.32 | 0.64 | 4.12 | -3.73 | |
Free Cash Flow | -46.08 | -55.57 | -34.69 | -24.88 | -19.09 | -15.81 | |
Free Cash Flow Margin | -1239.10% | -1226.92% | -629.85% | -556.08% | -2320.05% | - | |
Free Cash Flow Per Share | -1.28 | -1.54 | -1.01 | -1.03 | -1.16 | -1.97 | |
Levered Free Cash Flow | -31.06 | -27.75 | -24.24 | -16.82 | -9.83 | -4.81 | |
Unlevered Free Cash Flow | -26.58 | -26.11 | -24.24 | -16.78 | -9.44 | -4.23 | |
Change in Net Working Capital | -4.4 | -5.69 | 2.93 | 4.64 | -0.29 | -1.61 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.